+
Site Tour

Search

  • Clinical Data

    INSPIRED BY PATIENTS. MADE POSSIBLE BY YOU. TriClip TEER has shown meaningful outcomes in both real-world and randomized clinical data. The bRIGHT study and TRILUMINATE™ Pivotal trial demonstrated…
  • Patients who benefit

    A STATE-OF-THE-ART TREATMENT OPTION FOR PATIENTS AT HIGH RISK FOR SURGERY TriClip™ TEER is a low risk,5 minimally invasive, non-surgical treatment option for symptomatic patients with severe…
  • Features

    EXCEPTIONAL SAFETY4,5 MAXIMIZED EFFECTIVENESS4,5 LIFE-CHANGING IMPACT3-5 The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery2…
  • Clinical Data-Backup

    THE FIRST CHOICE TO RESTORE THE TRICUSPID VALVE1 TriClip TEER has shown meaningful outcomes in both real-world and randomized clinical data. bRIGHT and TRILUMINATE™ Pivotal Trials demonstrated the…
  • Features-Backup

    THE TRICUSPID VALVE HAS FINALLY MET ITS MATCH TRICLIP™ G4 TEER SYSTEM. UNMATCHED STABILITY, PRECISION, CONTROL.2 The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable…
  • Overview-Backup

    WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE FIND OUT MORE: DOWNLOAD FLYER SPECIALLY DESIGNED FOR THE TRICUSPID VALVE1 TriClip™ Transcatheter Edge-to-Edge (TEER) offers unmatched…
  • NAVITOR™ TAVI system features

    NAVITOR™ TAVI SYSTEM Navitor™ combines Navitor™ valves (available in four sizes) with the FlexNav™ delivery system to provide one TAVI system, optimized to give favorable clinical outcomes while…
  • LAAO Summit 2023

    ON DEMAND - LAAO SUMMIT 2023 12th Global Left Atrial Appendage Occlusion Summit LAAO SUMMIT 2023 - Welcome Left Atrial Appendage Occlusion therapy has become an established and increasingly…
  • Features

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion KEY FEATURES Innovative dual seal technology The Amulet™ Occluder's innovative…
  • Patients who benefit

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion Life-long medication to reduce stroke risk is not an option for many patients. The…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline